PMID: 11914098Mar 27, 2002Paper

Aldosterone synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart

Clinical Science
Mamoru SatohKatsuhiko Hiramori

Abstract

The pathway of tissue aldosterone production may exist in the heart, and may be an important contributory factor to myocardial fibrosis and cardiac remodelling in the failing heart. CYP11B2 (aldosterone synthase) catalyses the final step of aldosterone production. The aim of the present study was to determine whether CYP11B2 and CYP11B1 (11beta-hydroxylase) are expressed in myocardial tissues, and whether these enzymes contribute to collagen accumulation and myocardial dysfunction in the failing human heart. Endomyocardial tissues were obtained from 23 patients with chronic heart failure (CHF) and 10 controls. CYP11B2 and CYP11B1 mRNA levels were measured by real-time quantitative reverse transcriptase-PCR. The myocardial collagen volume fraction (CVF) was determined by digital planimetry. CYP11B2 mRNA expression was greater in the CHF group than in the controls (P<0.05), while CYP11B1 mRNA was barely expressed in either group. There was a positive correlation between CYP11B2 mRNA levels and CVF (r=0.64, P=0.001). CYP11B2 mRNA was particularly highly expressed in subgroups of CHF patients with a large left ventricular end-systolic diameter (>55 mm) or a low left ventricular ejection fraction (<30%). CYP11B2 mRNA expression and ...Continue Reading

Citations

Jul 23, 2005·Current Heart Failure Reports·Jamshid ShiraniVasken Dilsizian
Sep 10, 2002·Current Hypertension Reports·Jens GaedekeWayne A Border
May 26, 2005·Current Hypertension Reports·Paolo Magni, Marcella Motta
Dec 7, 2006·Current Hypertension Reports·Scott M Mackenzie, John Connell
May 12, 2004·Molecular and Cellular Endocrinology·C HeymesC Delcayre
Jun 26, 2003·Clinical and Experimental Pharmacology & Physiology·Eleanor Davies, Scott M MacKenzie
Feb 22, 2005·Congestive Heart Failure·Masahiro YoshidaIsamu Miyamori
Jul 19, 2006·International Journal of Clinical Practice·K Odedra, A Ferro
Jan 8, 2011·Biological & Pharmaceutical Bulletin·Yasutomo HoriSei-Ichi Higuchi
Jul 3, 2009·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Hiroko TanakaYoshifusa Aizawa
Oct 12, 2004·European Journal of Clinical Investigation·G Ertl
Apr 10, 2004·The Journal of Clinical Hypertension·Gary H Gibbons
Mar 25, 2004·Expert Review of Cardiovascular Therapy·Adelle DawsonAllan D Struthers
Jan 13, 2005·Canadian Journal of Physiology and Pharmacology·Arwen L HunterDavid J Granville
Apr 28, 2012·European Journal of Clinical Investigation·Paolo Galuppo, Johann Bauersachs
Apr 10, 2015·Journal of Cellular Physiology·Stephanie KönemannStephan B Felix
Mar 17, 2011·Medicine and Science in Sports and Exercise·Everton Crivoi Do CarmoEdilamar Menezes de Oliveira

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.